WELCURE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Welcure Drugs And Pharmaceuticals Altaf Hussain Resigns As MD, CFO
May 6 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
WELCURE DRUGS AND PHARMACEUTICALS- ALTAF HUSSAIN RESIGNS AS MD, CFO
Source text: ID:nBSE4dryL1
Further company coverage: WDP.BO
(([email protected];))
May 6 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
WELCURE DRUGS AND PHARMACEUTICALS- ALTAF HUSSAIN RESIGNS AS MD, CFO
Source text: ID:nBSE4dryL1
Further company coverage: WDP.BO
(([email protected];))
Welcure Drugs And Pharmaceuticals Approved Issue Of Warrants Worth 990 Million Rupees
June 10 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
APPROVED ISSUE OF WARRANTS WORTH 990 MILLION RUPEES ON PREFERENTIAL BASIS
Further company coverage: WDP.BO
(([email protected];))
June 10 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
APPROVED ISSUE OF WARRANTS WORTH 990 MILLION RUPEES ON PREFERENTIAL BASIS
Further company coverage: WDP.BO
(([email protected];))
Welcure Drugs And Pharmaceuticals Names Altaf Hussain Shah As MD, CFO
Feb 14 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
NAMES ALTAF HUSSAIN SHAH AS MD, CFO
Source text for Eikon: ID:nBSE48BGQr
Further company coverage: WDP.BO
(([email protected];))
Feb 14 (Reuters) - Welcure Drugs and Pharmaceuticals Ltd WDP.BO:
NAMES ALTAF HUSSAIN SHAH AS MD, CFO
Source text for Eikon: ID:nBSE48BGQr
Further company coverage: WDP.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Welcure Drugs&Pharma do?
Welcure Drugs & Pharmaceuticals Ltd manufactures and markets over hundred varieties of pharmaceutical formulations including antibiotics, vitamins, and analgesics in tablets, capsules, and dry syrups.
Who are the competitors of Welcure Drugs&Pharma?
Welcure Drugs&Pharma major competitors are Sizemasters Technolg, Standard Inds, MRP Agro Ltd., Prithvi Exchange (I), Royal Sense, Siddhika Coatings, Suchak Trading. Market Cap of Welcure Drugs&Pharma is ₹128 Crs. While the median market cap of its peers are ₹130 Crs.
Is Welcure Drugs&Pharma financially stable compared to its competitors?
Welcure Drugs&Pharma seems to be less financially stable compared to its competitors. Altman Z score of Welcure Drugs&Pharma is 0 and is ranked 8 out of its 8 competitors.
Does Welcure Drugs&Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Welcure Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Welcure Drugs&Pharma allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances
How strong is Welcure Drugs&Pharma balance sheet?
Welcure Drugs&Pharma balance sheet is weak and might have solvency issues
Is the profitablity of Welcure Drugs&Pharma improving?
The profit is oscillating. The profit of Welcure Drugs&Pharma is ₹4.45 Crs for TTM, -₹0.17 Crs for Mar 2024 and ₹0.1 Crs for Mar 2023.
Is the debt of Welcure Drugs&Pharma increasing or decreasing?
Yes, The net debt of Welcure Drugs&Pharma is increasing. Latest net debt of Welcure Drugs&Pharma is ₹123 Crs as of Mar-25. This is greater than Mar-24 when it was -₹0.04 Crs.
Is Welcure Drugs&Pharma stock expensive?
Welcure Drugs&Pharma is not expensive. Latest PE of Welcure Drugs&Pharma is 58.79, while 3 year average PE is 152. Also latest EV/EBITDA of Welcure Drugs&Pharma is 82.16 while 3yr average is 89.89.
Has the share price of Welcure Drugs&Pharma grown faster than its competition?
Welcure Drugs&Pharma has given better returns compared to its competitors. Welcure Drugs&Pharma has grown at ~143.97% over the last 1yrs while peers have grown at a median rate of 0.0%
Is the promoter bullish about Welcure Drugs&Pharma?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Welcure Drugs&Pharma?
There is Insufficient data to gauge this.